Samrat Pharma

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
228.25
-2.55 (-1.1%)
BSENSE

Sep 09, 03:30 PM

BSE+NSE Vol: 593

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 1.35% vs 1.52% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -120.89% vs 314.72% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 41.71% vs -1.88% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -146.57% vs 228.87% in Mar 2025

Compare Profit and Loss Results of Samrat Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
289.00
74.00
215.00
290.54%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
289.00
74.00
215.00
290.54%
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
6.00
-12.00
-200.00%
Raw Materials Consumed
289.00
63.00
226.00
358.73%
Power & Fuel Cost
1.00
3.00
-2.00
-66.67%
Employee Cost
2.00
5.00
-3.00
-60.00%
Operating Expenses
2.00
8.00
-6.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
291.00
91.00
200.00
219.78%
Operating Profit (PBDIT) excl Other Income
-2.00
-16.00
14.00
87.50%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
-1.00
-14.00
13.00
92.86%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
-2.00
-18.00
16.00
88.89%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
-2.00
-20.00
18.00
90.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-2.00
-20.00
18.00
90.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-3.00
-20.00
17.00
85.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
68.00
14.00
54.00
385.71%
Profit Available for appropriations
65.00
-5.00
70.00
1,400.00%
Appropriations
65.00
-5.00
70.00
1,400.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-10.72
-21.9
11.18
51.05%
Profit And Loss - Net Sales
Net Sales 289.72 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1.35% vs 1.52% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -2.14 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -120.89% vs 314.72% in Mar 2025

Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 41.71% vs -1.88% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax -3.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -146.57% vs 228.87% in Mar 2025